dc.relation.reference | Apple,R.J., Erlich,H.A., Klitz,W., Manos,M.M., Becker,T.M., Wheeler,C.M. "HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity." Nature Genetics. 1994; 6: 157-62.
Arbeit, J. M., P. M. Howley, D. Hanahan. "Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice." Proceedings of the National Academy of Sciences of the United States of America. 1996; 93: 2930-35.
Bernard,H.U., Chan,S.Y., Manos,M.M., Ong,C.K., Villa,L.L., Delius,H., Peyton,C.L., Bauer,H.M., Wheeler,C.M.. "Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. " Journal of Infectious Diseases. 1994; 170: 1077-85.
Beskow, A. H., A. M. Josefsson, U. B. Gyllensten. "HLA class II alleles associated with infection by HPV16 in cervical cancer in situ." International Journal of Cancer. 2001; 93: 817-22.
Bosch,F.X., Munoz,N., de Sanjose,S., Guerrerro,E., Ghaffari,A.M., Kaldor,J., Castellsague,X., Shah,K.V., Gaffari,A.M. "Importance of human papillomavirus endemicity in the incidence of cervical cancer: an extension of the hypothesis on sexual behavior. " Cancer Epidemiology, Biomarkers & Prevention. 1994; 3: 375-79.
Bosch, F. X., "Epidemiology of human papillomavirus infections: new options for cervical cancer prevention." Salud Publica de Mexico. 2003; 45: Suppl-39.
Breitburd,F., Ramoz,N., Salmon,J., Orth,G. "HLA control in the progression of human papillomavirus infections. " Seminars in Cancer Biology. 1996; 7: 359-71.
Bunce, M., N. T. Young, K. I. Welsh. "Molecular HLA typing--the brave new world." Transplantation. 1997; 64: 1505-13.
Burd, E. M. "Human papillomavirus and cervical cancer. " Clinical Microbiology Reviews. 2003; 16: 1-17.
Castellsague, X., F. X. Bosch, N. Munoz. "Environmental co-factors in HPV carcinogenesis." Virus Research. 2002; 89: 191-99.
Castle,P.E., Hillier,S.L., Rabe,L.K., Hildesheim,A., Herrero,R., Bratti,M.C., Sherman,M.E., Burk,R.D., Rodriguez,A.C., Alfaro,M., Hutchinson,M.L., Morales,J., Schiffman,M. "An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus." Cancer Epidemiology, Biomarkers & Prevention. 2001; 10: 1021-27.
Chan,P.K., Li,W.H., Chan,M.Y., Ma,W.L., Cheung,J.L., Cheng,A.F. "High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions." Journal of Medical Virology. 1999; 59: 232-38.
Clifford,G.M., Smith,J.S., Plummer,M., Munoz,N., Franceschi,S. "Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis." British Journal of Cancer. 2003; 88: 63-73.
Cuzick,J., Terry,G., Ho,L., Monaghan,J., Lopes,A., Clarkson,P., Duncan,I. "Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women." British Journal of Cancer. 2000; 82: 1348-52.
Dillner,J., Lehtinen,M., Bjorge,T., Luostarinen,T., Youngman,L., Jellum,E., Koskela,P., Gislefoss,R.E., Hallmans,G., Paavonen,J., Sapp,M., Schiller,J.T., Hakulinen,T., Thoresen,S., Hakama,M. "Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer." Journal of the National Cancer Institute. 1997; 89: 1293-99.
Donaldson,P.T., Ho,S., Williams,R., Johnson,P.J. "HLA class II alleles in Chinese patients with hepatocellular carcinoma." Liver. 2001; 21: 143-48.
Elson,D.A., Riley,R.R., Lacey,A., Thordarson,G., Talamantes,F.J., Arbeit,J.M. "Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis." Cancer Research. 2000; 60: 1267-75.
Forslund,O., Antonsson,A., Edlund,K., van den Brule,A.J., Hansson,B.G., Meijer,C.J., Ryd,W., Rylander,E., Strand,A., Wadell,G., Dillner,J., Johansson,B. "Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women." Journal of Medical Virology. 2002; 66: 535-41.
Ghaderi,M., Wallin,K.L., Wiklund,F., Zake,L.N., Hallmans,G., Lenner,P., Dillner,J., Sanjeevi,C.B. "Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes." International Journal of Cancer. 2002; 100: 698-701.
Guerrero,E., Daniel,R.W., Bosch,F.X., Castellsague,X., Munoz,N., Gili,M., Viladiu,P., Navarro,C., Zubiri,M.L., Ascunce,N. "Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. " Journal of Clinical Microbiology. 1992; 30: 2951-59.
Helland,A., Olsen,A.O., Gjoen,K., Akselsen,H.E., Sauer,T., Magnus,P., Borresen-Dale,A.L., Ronningen,K.S. "An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women." International Journal of Cancer. 1998; 76: 19-24.
Hildesheim,A., Schiffman,M.H., Tsukui,T., Swanson,C.A., Lucci,J.,III, Scott,D.R., Glass,A.G., Rush,B.B., Lorincz,A.T., Corrigan,A., Burk,R.D., Helgesen,K., Houghten,R.A., Sherman,M.E., Kurman,R.J., Berzofsky,J.A., Kramer,T.R. "Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease." Cancer Epidemiology, Biomarkers & Prevention. 1997; 6: 807-13.
Hildesheim,A., Herrero,R., Castle,P.E., Wacholder,S., Bratti,M.C., Sherman,M.E., Lorincz,A.T., Burk,R.D., Morales,J., Rodriguez,A.C., Helgesen,K., Alfaro,M., Hutchinson,M., Balmaceda,I., Greenberg,M., Schiffman,M. "HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica." British Journal of Cancer. 2001; 84: 1219-26.
Hildesheim,A., Apple,R.J., Chen,C.J., Wang,S.S., Cheng,Y.J., Klitz,W., Mack,S.J., Chen,I.H., Hsu,M.M., Yang,C.S., Brinton,L.A., Levine,P.H., Erlich,H.A. "Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan." Journal of the National Cancer Institute. 2002a; 94: 1780-89.
Hildesheim, A. S. S. Wang. "Host and viral genetics and risk of cervical cancer: a review." Virus Research. 2002b; 89: 229-40.
Ho,G.Y., Bierman,R., Beardsley,L., Chang,C.J., Burk,R.D. "Natural history of cervicovaginal papillomavirus infection in young women." New England Journal of Medicine. 1998; 338: 423-28.
Huang,S., Afonina,I., Miller,B.A., Beckmann,A.M. "Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. " International Journal of Cancer. 1997; 70: 408-11.
Klein, J., A. Sato. "The HLA system. First of two parts. " New England Journal of Medicine. 2000a; 343: 702-09.
Klein, J., A. Sato. "The HLA system. Second of two parts. " New England Journal of Medicine. 2000b; 343: 782-86.
Krul,E.J., Schipper,R.F., Schreuder,G.M., Fleuren,G.J., Kenter,G.G., Melief,C.J. "HLA and susceptibility to cervical neoplasia." Human Immunology. 1999; 64: 337-42.
Lehtinen,M., Koskela,P., Jellum,E., Bloigu,A., Anttila,T., Hallmans,G., Luukkaala,T., Thoresen,S., Youngman,L., Dillner,J., Hakama,M. "Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries." American Journal of Epidemiology. 2002; 156: 687-92.
Liaw,K.L., Hsing,A.W., Chen,C.J., Schiffman,M.H., Zhang,T.Y., Hsieh,C.Y., Greer,C.E., You,S.L., Huang,T.W., Wu,T.C. "Human papillomavirus and cervical neoplasia: a case-control study in Taiwan." International Journal of Cancer. 1995; 91: 565-71.
Liaw,K.L., Glass,A.G., Manos,M.M., Greer,C.E., Scott,D.R., Sherman,M., Burk,R.D., Kurman,R.J., Wacholder,S., Rush,B.B., Cadell,D.M., Lawler,P., Tabor,D., Schiffman,M. "Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions." Journal of the National Cancer Institute. 1999; 62: 954-60.
Lin,M., Chu,C.C., Chang,S.L., Lee,H.L., Loo,J.H., Akaza,T., Juji,T., Ohashi,J., Tokunaga,K. "The origin of Minnan and Hakka, the so-called "Taiwanese", inferred by HLA study." Tissue Antigens. 2001; 57: 192-99.
Lin,P., Koutsky,L.A., Critchlow,C.W., Apple,R.J., Hawes,S.E., Hughes,J.P., Toure,P., Dembele,A., Kiviat,N.B. "HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women." Cancer Epidemiology, Biomarkers & Prevention. 2001; 10: 1037-45.
Maciag,P.C., Schlecht,N.F., Souza,P.S., Franco,E.L., Villa,L.L., Petzl-Erler,M.L. "Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women." Cancer Epidemiology, Biomarkers & Prevention. 2000; 9: 1183-91.
Maciag,P.C., Schlecht,N.F., Souza,P.S., Rohan,T.E., Franco,E.L., Villa,L.L. "Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection." Journal of Infectious Diseases. 2002; 186: 164-72.
Madeleine,M.M., Brumback,B., Cushing-Haugen,K.L., Schwartz,S.M., Daling,J.R., Smith,A.G., Nelson,J.L., Porter,P., Shera,K.A., McDougall,J.K., Galloway,D.A. "Human leukocyte antigen class II and cervical cancer risk: a population-based study." Journal of Infectious Diseases. 2002; 186: 1565-74.
Magnusson,P.K.E., Enroth,H., Eriksson,I., Held,M., Nyren,O., Engstrand,L., Hansson,L.E., Gyllensten,U.B. "Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori." Cancer Research. 2001; 61: 2684-89.
Moscicki, A. B., Hills,N., Shiboski,S., Powell,K., Jay,N. Hanson,E., Miller,S., Clayton,L., Farhat,S., Broering,J., Darragh,T., Palefsky,J. "Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females." JAMA. 2001; 285: 2995-3002.
Munoz,N., Bosch,F.X., de Sanjose,S., Herrero,R., Castellsague,X., Shah,K.V., Snijders,P.J., Meijer,C.J., International Agency for Research on Cancer Multicenter Cervical Cancer Study Group "Epidemiologic classification of human papillomavirus types associated with cervical cancer. " New England Journal of Medicine. 2003; 348: 518-27.
Nindl,I., Lotz,B., Kuhne-Heid,R., Endisch,U., Schneider,A. "Distribution of 14 high risk HPV types in cervical intraepithelial neoplasia detected by a non-radioactive general primer PCR mediated enzyme immunoassay." Journal of Clinical Pathology. 1999; 52: 17-22.
Odunsi,K., Terry,G., Ho,L., Bell,J., Cuzick,J., Ganesan,T.S. "Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles." International Journal of Cancer. 1996; 67: 595-602.
Santos,C., Munoz,N., Klug,S., Almonte,M., Guerrero,I., Alvarez,M., Velarde,C., Galdos,O., Castillo,M., Walboomers,J., Meijer,C., Caceres,E. "HPV types and cofactors causing cervical cancer in Peru." British Journal of Cancer. 2001; 85: 966-71.
Sasagawa,T., Basha,W., Yamazaki,H., Inoue,M. "High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women." Cancer Epidemiology, Biomarkers & Prevention. 2001; 10: 45-52.
Schiff,M., Becker,T.M., Masuk,M., Asselt-King,L., Wheeler,C.M., Altobelli,K.K., North,C.Q., Nahmias,A.J. "Risk factors for cervical intraepithelial neoplasia in southwestern American Indian women." American Journal of Epidemiology. 2000; 152: 716-26.
Schiffman, M. H., P. Castle. "Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. " Journal of the National Cancer Institute. 2003; 95: E2.
Shen,S.W., Hu,C.Y., Lin,C.Y., Yang,Y.C., Hsieh,R.P. "Human leukocyte antigen polymorphisms in the Taiwanese population." Journal of the Formosan Medical Association. 1999; 98: 11-18.
Shew,M.L., McGlennen,R., Zaidi,N., Westerheim,M., Ireland,M., Anderson,S. "Oestrogen receptor transcripts associated with cervical human papillomavirus infection." Sexually Transmitted Infections. 2002; 78: 210-14.
Thio,C.L., Carrington,M., Marti,D., O'Brien,S.J., Vlahov,D., Nelson,K.E., Astemborski,J., Thomas,D.L. "Class II HLA alleles and hepatitis B virus persistence in African Americans." Journal of Infectious Diseases. 1999; 179: 1004-06.
Thomas,D.B., Ray,R.M., Koetsawang,A., Kiviat,N., Kuypers,J., Qin,Q., Ashley,R.L., Koetsawang,S. "Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA." American Journal of Epidemiology. 2001a; 153: 723-31.
Thomas,D.B., Qin,Q., Kuypers,J., Kiviat,N., Ashley,R.L., Koetsawang,A., Ray,R.M., Koetsawang,S. "Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas." American Journal of Epidemiology. 2001b; 153: 732-39.
Waggoner, S. E. "Cervical cancer." Lancet. 2003; 351: 2217-25.
Wang,S.S., Wheeler,C.M., Hildesheim,A., Schiffman,M., Herrero,R., Bratti,M.C., Sherman,M.E., Alfaro,M., Hutchinson,M.L., Morales,J., Lorincz,A., Burk,R.D., Carrington,M., Erlich,H.A., Apple,R.J. "Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica." Journal of Infectious Diseases. 2001; 184: 1310-14.
Wang,S.S., Hildesheim,A., Gao,X., Schiffman,M., Herrero,R., Bratti,M.C., Sherman,M.E., Barnes,W.A., Greenberg,M.D., McGowan,L., Mortel,R., Schwartz,P.E., Zaino,R.J., Glass,A.G., Burk,R.D., Karacki,P., Carrington,M. "Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. " Journal of Infectious Diseases. 2002; 186: 598-605.
Wolf,J.K., Franco,E.L., Arbeit,J.M., Shroyer,K.R., Wu,T.C., Runowicz,C.D., Tortolero-Luna,G., Herrero,R., Crum,C.P. et al. "Innovations in understanding the biology of cervical cancer." Cancer. 2003; 98: Suppl-9.
游山林 (1995),『台灣地區子宮頸癌變之流行病學研究』,台灣大學公共衛生研究所博士論文。 | zh_TW |